Tag: HER2

Piramal Pharma Solutions (PPS) is handling the production of Bolt’s Boltbody™ Immune Stimulating Antibody Conjugate (ISAC), BDC-1001, currently in a first-in-human Phase 1/2 clinical study for the treatment of cancer patients.....................